Home / EDTXF : OTC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does EDTXF make money? Does EDTXF have pricing power? What's the Earnings Whisper? Will EDTXF profit more as the business scales? What is EDTXF's management track record? Is EDTXF's current price justified?

Spectral Medical Inc

$0.91 -$0.13 (-12.88%)

OTC · 11 Sep 2026 20:00 UTC

Previous Close

$0.91

Day Range

$0.91$0.92

Year Range

$0.81$1.21

Market Cap

265.96M

AVG Volume

9.44K

Trailing/Forward PE

-9.8/44.11

PEG ratio

0.05

Dividend Yield

Next Earnings Date

2026-11-06

Primary Exchange

Other OTC

Revenue (CAD)

EDTXF Revenue (CAD) by year
Period	Revenue (CAD)
2025	2.44M
2024	2.29M
2023	1.6M
2022	1.67M
2021	2.05M
2020	2.1M
2019	2.87M
2018	3.84M
2017	3.81M
2016	3.54M

Net Income (CAD)

EDTXF Net Income (CAD) by year
Period	Net Income (CAD)
2025	-47.69M
2024	-15.4M
2023	-15.66M
2022	-11.25M
2021	-8.79M
2020	-9.1M
2019	-4.86M
2018	-2.49M
2017	-3.94M
2016	-10.15M

Operating Income (CAD)

EDTXF Operating Income (CAD) by year
Period	Operating Income (CAD)
2025	-11.54M
2024	-12.55M
2023	-11.69M
2022	-9.44M
2021	-8.6M
2020	-9.09M
2019	-4.71M
2018	-1.59M
2017	-3.94M
2016	-10.22M

EBITDA (CAD)

EDTXF EBITDA (CAD) by year
Period	EBITDA (CAD)
2025	-43.35M
2024	-10.6M
2023	-11.44M
2022	-6.76M
2021	-8.46M
2020	-8.79M
2019	-4.5M
2018	-1.68M
2017	-3.13M
2016	-9.21M

Cash Flows (CAD)

EDTXF Cash Flows (CAD) by year
Period	Cash Flows (CAD)
2025	-10.19M
2024	-8.85M
2023	-10.91M
2022	-9.96M
2021	-9.18M
2020	-639K
2019	-2.9M
2018	-2.37M
2017	-3.73M
2016	-11.25M

EPS (CAD)

EDTXF EPS (CAD) by year
Period	EPS (CAD)
2025	-0.17
2024	-0.06
2023	-0.06
2022	-0.04
2021	-0.03
2020	-0.04
2019	-0.02
2018	-0.01
2017	-0.02
2016	-0.05

Expenses (CAD)

EDTXF Expenses (CAD) by year
Period	Expenses (CAD)
2025	12.53M
2024	14.72M
2023	14.3M
2022	11.1M
2021	11.02M
2020	12.71M
2019	8.39M
2018	5.24M
2017	6.82M
2016	12.19M

Cash & Debt (CAD)

EDTXF Cash & Debt (CAD) by year
Period	Cash & Debt (CAD)
2025	4.07M
2024	2.99M
2023	2.95M
2022	8.41M
2021	8.89M
2020	5.81M
2019	1.44M
2018	4.37M
2017	1.45M
2016	5.08M

Debt ratios

EDTXF Debt ratios by year
Period	Debt ratios
2025	-0.24
2024	-0.32
2023	-0.16
2022	0.06
2021	0.35
2020	0.28
2019	0.04
2018	0.19

Margins

EDTXF Margins by year
Period	Margins
2025	12.33%
2024	-12.69%
2023	-32.1%
2022	58.97%
2021	59.45%
2020	70.11%
2019	77.34%
2018	90.42%
2017	87.47%
2016	80.08%

Return on Capital

EDTXF Return on Capital by year
Period	Return on Capital
2025	68.45%
2024	55.92%
2023	94.64%
2022	445.9%
2021	-215.16%
2020	1359.94%
2019	-215.04%
2018	-39.07%
2017	-138.94%
2016	-174.32%

Shares Outstanding

EDTXF Shares Outstanding by year
Period	Shares Outstanding
2025	291.7M
2024	280.05M
2023	278.58M
2022	274.96M
2021	267.89M
2020	225.84M
2019	225.84M
2018	225.72M
2017	207.48M
2016	207.08M

Dividends (CAD)

EDTXF Dividends (CAD) by year
Period	Dividends (CAD)
2011	0.12

Book Value Per Share (CAD)

EDTXF Book Value Per Share (CAD) by year
Period	Book Value Per Share (CAD)
2025	-0.24
2024	-0.1
2023	-0.06
2022	-0.01
2021	0.02
2020	-0
2019	0.01
2018	0.03
2017	0.01
2016	0.03

Total Assets (CAD)

EDTXF Total Assets (CAD) by year
Period	Total Assets (CAD)
2025	6.1M
2024	5.32M
2023	5.21M
2022	12M
2021	11.55M
2020	8.16M
2019	4.01M
2018	6.98M
2017	3.47M
2016	7.1M

Free Cash Flow Yield

EDTXF Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	-3.02%
Sep 26	-3%
Aug 26	-2.82%
Aug 26	-2.84%
Aug 26	-2.71%
Aug 26	-2.73%
Jul 26	-2.74%
Jul 26	-2.76%
Jul 26	-2.71%
Jul 26	-2.75%
Jul 26	-2.85%
Jun 26	-2.6%
Jun 26	-2.56%
Jun 26	-2.54%
Jun 26	-2.46%
May 26	-2.44%
May 26	-2.5%
May 26	-2.49%
May 26	-2.48%
May 26	-2.59%
Apr 26	-2.51%
Apr 26	-2.5%
Apr 26	-2.5%
Apr 26	-2.51%
Mar 26	-2.23%
Mar 26	-2.53%
Mar 26	-2.48%
Mar 26	-2.36%
Feb 26	-2.41%
Feb 26	-2.42%
Feb 26	-2.44%
Feb 26	-2.41%
Jan 26	-2.49%
Jan 26	-2.37%
Jan 26	-2.29%
Jan 26	-2.22%
Jan 26	-2.23%
Dec 25	-2.58%
Dec 25	-2.64%
Dec 25	-2.56%
Dec 25	-2.54%
Nov 25	-2.61%
Nov 25	-2.45%
Nov 25	-2.3%
Nov 25	-2.29%
Oct 25	-2.21%
Oct 25	-2.09%
Oct 25	-2.13%
Oct 25	-2.28%
Oct 25	-2.29%
Sep 25	-2.13%
Sep 25	-2.13%
Sep 25	-1.85%
Sep 25	-1.96%
Aug 25	-2.14%
Aug 25	-2.27%
Aug 25	-2.89%
Aug 25	-3.91%
Aug 25	-3.75%
Jul 25	-3.8%
Jul 25	-3.87%
Jul 25	-3.72%
Jul 25	-3.9%
Jun 25	-3.78%
Jun 25	-3.77%
Jun 25	-3.63%
Jun 25	-3.81%
May 25	-3.73%
May 25	-3.75%
May 25	-3.87%
May 25	-3.64%
May 25	-4%
Apr 25	-4.04%
Apr 25	-3.94%
Apr 25	-4.44%
Apr 25	-4.43%
Mar 25	-4.03%
Mar 25	-4.48%
Mar 25	-4.3%
Mar 25	-4.2%
Feb 25	-4.41%
Feb 25	-4.6%
Feb 25	-4.75%
Feb 25	-5.27%
Jan 25	-5.58%
Jan 25	-5.5%
Jan 25	-5.98%
Jan 25	-5.34%
Jan 25	-5.47%
Dec 24	-6.32%
Dec 24	-6.73%
Dec 24	-6.25%
Dec 24	-5.93%
Nov 24	-5.42%
Nov 24	-6%
Nov 24	-5.44%
Nov 24	-5.46%
Nov 24	-5.12%
Oct 24	-4.49%
Oct 24	-5.11%

Price to Sales

EDTXF Price to Sales by year
Period	Price to Sales
Sep 26	133.35
Sep 26	134.51
Aug 26	142.86
Aug 26	142.27
Aug 26	148.7
Aug 26	147.9
Jul 26	147.07
Jul 26	145.97
Jul 26	148.79
Jul 26	146.6
Jul 26	141.39
Jun 26	160.64
Jun 26	162.96
Jun 26	164.43
Jun 26	169.84
May 26	171.3
May 26	166.69
May 26	167.49
May 26	168.26
May 26	161.08
Apr 26	166.52
Apr 26	166.8
Apr 26	166.98
Apr 26	166.27
Mar 26	151.78
Mar 26	133.29
Mar 26	136.38
Mar 26	143.41
Feb 26	140.32
Feb 26	139.69
Feb 26	138.65
Feb 26	140.23
Jan 26	135.79
Jan 26	142.4
Jan 26	147.6
Jan 26	151.99
Jan 26	151.45
Dec 25	143.06
Dec 25	140.12
Dec 25	144.18
Dec 25	145.26
Nov 25	141.48
Nov 25	150.53
Nov 25	160.89
Nov 25	161.19
Oct 25	167
Oct 25	176.34
Oct 25	173.49
Oct 25	162.21
Oct 25	161.61
Sep 25	193.92
Sep 25	193.39
Sep 25	223.2
Sep 25	210.3
Aug 25	192.92
Aug 25	181.49
Aug 25	142.79
Aug 25	105.51
Aug 25	110.16
Jul 25	108.6
Jul 25	106.56
Jul 25	110.99
Jul 25	105.75
Jun 25	102.26
Jun 25	102.62
Jun 25	106.55
Jun 25	101.5
May 25	103.69
May 25	103.25
May 25	100
May 25	106.2
May 25	96.8
Apr 25	95.68
Apr 25	98.21
Apr 25	87.14
Apr 25	87.4
Mar 25	103.89
Mar 25	93.35
Mar 25	97.29
Mar 25	99.64
Feb 25	94.91
Feb 25	90.89
Feb 25	88.09
Feb 25	79.41
Jan 25	75.01
Jan 25	76.07
Jan 25	69.93
Jan 25	78.4
Jan 25	76.41
Dec 24	72.53
Dec 24	68.1
Dec 24	73.36
Dec 24	77.34
Nov 24	84.55
Nov 24	76.43
Nov 24	84.23
Nov 24	83.97
Nov 24	89.56
Oct 24	102.01
Oct 24	89.65

Price/Operating Cashflow

EDTXF Price/Operating Cashflow by year
Period	Price/Operating Cashflow
Dec 20	72.96
Dec 20	80.98
Dec 20	70
Dec 20	68.71
Nov 20	69.72
Nov 20	67.83
Nov 20	76.09
Nov 20	73.05
Oct 20	67.45
Oct 20	73.31
Oct 20	79.77
Oct 20	84.24
Oct 20	89.42
Sep 20	50.66
Sep 20	56.32
Sep 20	56.15
Sep 20	58.08
Aug 20	59.89
Aug 20	58.64
Aug 20	60.29
Aug 20	60.11
Jul 20	57.34
Jul 20	56.85
Jul 20	61.79
Jul 20	59.18
Jul 20	64.7

Price to Book

EDTXF Price to Book by year
Period	Price to Book
Sep 22	57.12
Sep 22	56.29
Sep 22	55.71
Sep 22	55.59
Aug 22	55.19
Aug 22	52.37
Aug 22	60.61
Aug 22	67.04
Jul 22	65.52
Jul 22	68.08
Jul 22	52.58
Jul 22	45.13
Jul 22	49.64
Jun 22	26.37
Jun 22	26.81
Jun 22	20.13
Jun 22	20.64
May 22	17.29
May 22	19.37
May 22	19.55
May 22	20.46
Apr 22	20.67
Apr 22	22.51
Apr 22	22.31
Apr 22	22.27
Apr 22	19.31
Mar 22	12.17
Mar 22	14.33
Mar 22	14.43
Mar 22	14.53
Feb 22	13.27
Feb 22	14.34
Feb 22	13.81
Feb 22	12.3
Jan 22	10.62
Jan 22	10.62
Jan 22	12.04
Jan 22	10.63
Dec 21	8.94
Mar 21	89.17
Mar 21	93.68
Mar 21	86.64
Mar 21	110.99
Feb 21	112.59
Feb 21	115.66
Feb 21	117.07
Feb 21	100.47
Jan 21	82.74
Jan 21	74.29
Jan 21	71.46
Jan 21	75.48
Dec 20	70.9
Dec 20	31.25
Dec 20	34.69
Dec 20	29.99
Dec 20	29.44
Nov 20	29.86
Nov 20	29.06
Nov 20	32.6
Nov 20	31.29
Oct 20	28.89
Oct 20	31.4
Oct 20	34.17
Oct 20	36.08
Oct 20	38.3
Sep 20	357.54
Sep 20	397.5
Sep 20	396.25
Sep 20	409.88
Aug 20	422.69
Aug 20	413.85
Aug 20	425.46
Aug 20	424.25
Jul 20	404.68
Jul 20	401.21
Jul 20	436.08
Jul 20	417.67
Jul 20	456.63
Jun 20	56.21
Jun 20	61.75
Jun 20	64.73
Jun 20	64.36
May 20	63.29
May 20	64.37
May 20	66.27
May 20	68.29
May 20	66.87
Apr 20	61.52
Apr 20	67.03
Apr 20	51.66
Apr 20	50.9
Mar 20	30.17
Mar 20	29.33
Mar 20	29.57
Mar 20	39.7
Feb 20	41.4
Feb 20	42.4
Feb 20	46.74
Feb 20	45.8
Jan 20	42.94

No video analysis for this stock yet. Request one from our team.

News: EDTXF

globenewswire.com · 25 Jun 2026

Spectral Medical Announces U.S. FDA Filing of PMA Application for PMX

TORONTO, June 25, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced that the U.S. Food and Drug Administration (“FDA”) has completed its filing review and formally filed the Company's Premarket Approval (“PMA”) application for PMX, the Company's endotoxin removal therapy for patients with endotoxic septic shock (“ESS”). FDA acceptance for filing of the PMA application follows completion of the Agency's filing review process and confirms that the application contains all the information needed to proceed with the substantive review.

AI Analysis

Spectral Medical Inc

Video analysis: EDTXF

News: EDTXF

Spectral Medical Announces U.S. FDA Filing of PMA Application for PMX

Similar companies